<DOC>
	<DOCNO>NCT00411827</DOCNO>
	<brief_summary>Purpose : To develop screen metric examine characteristic preoperative tear film intracellular signaling pathway conjunctival goblet cell order determine certain characteristic might predict patient experience serious dry eye symptom complication refractive surgery . Research Design : This study twelve-month prospective non-randomized investigation . Methodology : In conjunction psychometric questionnaires various measure tear film quality ( e.g . Schirmer 's test , tear break time , etc ) , impression cytology use ass intracellular signal pathway conjunctival goblet cell determine alteration pathway exist . Alterations pathway would result reduce response mucin secrete conjunctival goblet cell thereby promote development dry eye refractive surgery .</brief_summary>
	<brief_title>Goblet Cell Response Dry Eye Symptoms After PRK LASIK</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<criteria>Subjects recruit active duty soldier request refractive surgery . Subjects must eligible medical care WRAMC . 1 . Male female , race , least 21 year old old 40 year old time preoperative examination , sign informed consent . The low age limit 21 year intend ensure documentation refractive stability minimal age require FDA informed consent LASIK surgery . 2 . Manifest refractive spherical equivalent ( MSE ) 10.00 diopter spectacle plane refractive cylinder 3.00 D. 3 . Best spectacle correct visual acuity 20/20 good eye . 4 . Patients willing fill dry eye questionnaire . 5 . Demonstrated refractive stability , confirm clinical record . Neither spherical cylindrical portion refraction may change 0.50D 12 month period immediately precede baseline examination , confirm clinical record . 6 . All patient must willing return WRAMC Center Refractive Surgery follow visit Day1 , Day 3 , Day 7 , 1 , 3 , 6 , 12 month surgery . 7 . Located great Washington DC area 14month period . 8 . Consent subject 's command ( active duty ) participate study . 9 . Access transportation meet followup requirement . 1 . Previous surgery trauma study eye . 2 . Dry eye reflect Schirmer 's test anesthesia 0 , subjective complaint symptom dry eye , finding slit lamp exam would consistent dry eye ( e.g . superficial punctuate keratitis ) . 3 . Female subject pregnant , breastfeed intend become pregnant study . This standard care exclusion refractive surgery Walter Reed Refractive Surgery Center medication routinely give part procedure . Standard care analgesia consist medication ( e.g . narcotic ) label Pregnancy Category `` C '' FDA . Teratogenic effect know , however , physical dependence neonate may occur mother give narcotic . Female subject give urine pregnancy test prior participate study rule pregnancy . 4 . Concurrent topical systemic medication may impair heal , include corticosteroid , antimetabolite , isotretinoin ( Accutane ) , amiodarone hydrochloride ( Cordarone ) and/or sumatriptan ( Imitrex ) . 5 . Medical condition ( ) , , judgment investigator , may impair heal , include limited : collagen vascular disease , autoimmune disease , immunodeficiency disease , ocular herpes zoster simplex . 6 . Active ophthalmic disease , neovascularization cornea within 1mm intended ablation zone , clinically significant lens opacity . 7 . Evidence glaucoma intraocular pressure great 22 mm Hg baseline . 8 . Evidence keratoconus , corneal irregularity , abnormal videokeratography either eye . 9 . History recurrent erosion epithelial basement dystrophy . 10 . Patients know sensitivity inappropriate responsiveness medication use postoperative course . 11 . Any physical mental impairment would preclude participation examination .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Cytology</keyword>
	<keyword>Keratomileusis , Laser In Situ</keyword>
	<keyword>Keratectomy , Photorefractive , Excimer Laser</keyword>
</DOC>